Funding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →
Leo Cancer Care has raised $65M in a Series D round led by Yu Galaxy, aiming to enhance its integrated upright cancer care platform and accelerate its commercial deployment.
Leo Cancer Care announced the close of an oversubscribed $65 million Series D financing round. Led by Yu Galaxy, the investment will support manufacturing and commercial deployment of its upright cancer care platform. Continued clinical and product development is also a focus. This financing follows the world’s first compact upright proton treatment at Stanford Medicine.
Company Information
Company
Leo Cancer Care
Location
Surrey, England, United Kingdom
About
Leo Cancer Care is a company dedicated to delivering radiation therapy in a more human way. Their unique upright patient positioning and CT imaging system, named Marie®, offers a gantry-less approach and aims to reduce internal organ movement in patients receiving upright therapy. The company aims to expand its global footprint and is dedicated to providing more personalized care for cancer patients.
Related People
Suggested for you
1 contact
Verified contactsNo contacts on file at Leo Cancer Care yet.
Predictive Intelligence
Strategic
ML-powered predictions for Leo Cancer Care's next move
SurreyBiotechnologyHealth CareMedicalMedical Device